Skip to content
Open access

De novo design of ligand binding and sensing with a physics based generative approach

Jul 2026 · bioRxiv · 0 citations · 44 references
Biology

TL;DR

A physics-based generative approach for the de novo creation of proteins that bind small molecules and metal ions is introduced, allowing for precise architectural control of the protein–ligand complex and facilitating the development of biosensors based on either ligand-triggered protein reassociation via split-protein reassembly or ligand-induced protein folding.

Abstract

The de novo design of ligand-binding proteins has tremendous potential to revolutionize biosensor technology, yet converting these designs into functional sensors remains a major challenge due to the need for ligand-induced conformational changes or modulation of protein–protein interactions. Here, we introduce a physics-based generative approach for the de novo creation of proteins that bind small molecules and metal ions. Our method achieves customizable ligand-binding pocket formation in parallel with simulated protein folding, allowing for precise architectural control of the protein–ligand complex and facilitating the development of biosensors based on either ligand-triggered protein reassociation via split-protein reassembly or ligand-induced protein folding. We demonstrate the versatility of our computational method through successful designs targeting five small molecules, including the very small neurotransmitters serotonin and dopamine, and two metal ions. Biophysical characterization confirmed correct ligand binding, and crystal structures closely matched computational models. We demonstrated the biosensor engineering potential of these designs by constructing serotonin and dopamine sensors using a split protein strategy and explored several approaches to enhance sensor activity. Additionally, we developed a zinc sensor through a zinc-induced protein folding mechanism. Overall, our physics-based generative approach provides a robust framework for the de novo design of ligand-binding proteins, opening new avenues for the development of ligand-responsive biosensors.

Read PDF

Similar papers

Open access Aug 2026

De novo design of small-molecule–induced conformational change

Many biological proteins function by changing shape upon small-molecule binding. Here, we present a general strategy for designing de novo proteins that undergo small-molecule-induced conformational change. Our approach converts a preorganized small-molecule binding protein into a ligand-responsive shape-changer by adding a mobile lid domain that closes behind the ligand upon binding. Using this strategy, we converted an exatecan-binding protein into a drug-induced conformational switch. The lidded proteins showed considerably stronger binding affinity in the sub-nanomolar regime, 100-fold greater specificity to exatecan over a similar molecule, and ligand residence times up to several months, with tunable binding kinetics. We turned one design into a genetically encodable fluorescent biosensor of the drug, enabling potential clinical applications. Our results open the door to programming complex molecular function using vast chemical space.

Jeffrey Chang, Nicholas F. Polizzi · 0 citations
Jul 2026

Peptide ligand discovery of G protein-coupled receptors

This Primer outlines experimental and computational workflows tailored to peptide–GPCR interactions, including in silico peptide mining, deorphanization strategies, library-based screening platforms, modern pathway-resolved biosensor assays, and approaches for peptide stabilization and optimization strategies to address their pharmacokinetic limitations.

J. Hermes, Marin Matic, H. Yeung et al. · 0 citations
Open access Aug 2026

NACraft: Programmatic nucleic-acid aptamer design via all-atom structure-model feedback

NACraft, a training-free and programmatic framework for all-atom nucleic-acid aptamer design based on backpropagation through structure-model feedback, is presented, demonstrating the effectiveness and versatility of NACraft and extending structure-model hallucination toward programmatic nucleic-acid aptamer design.

He-Qin Zhu, Jiaqi Wang, Wei-Bo Zhao et al. · 0 citations
Aug 2026

HighMorph: De Novo Cyclic Peptide Sequence Design via Protein-Protein Interaction Recapitulation.

HighMorph is presented, an interaction-guided framework that combines protein–protein interaction information with artificial intelligence for rational cyclic peptide design and provides insights for developing therapeutics targeting challenging protein interfaces.

M. Lan, Chengyun Zhang, Wentong Wang et al. · 0 citations
Jul 2026

Comparative Assessment of DNA Force Fields for Small-Molecule Ligand Binding via Multicanonical MD-Based Dynamic Docking Simulations.

Evaluating modern AMBER-based parametrizations across diverse structural motifs, including aptamers, duplexes, and quadruplex-duplex hybrids, provides critical insights for developing next-generation DNA force fields capable of accurately modeling non-native structures and enabling balanced sampling essential for predicting ligand binding in diverse biological contexts.

G. Bekker, Y. Fukunishi, Junichi Higo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.